Ethics approval and consent to participate
The participants who met the inclusion criteria were fully informed
about the study’s protocol. The study protocol was approved by the
Ethics Committee of Ahvaz University of Medical Sciences
(IR.AJUMS.REC.1397.817). Each subject signed the written informed
consent. This study was conducted in accordance with the Declaration of
Helsinki.
Disclosure: Dr. James R. Hébert owns controlling interest in
Connecting Health Innovations LLC (CHI), a company that has licensed the
right to his invention of the dietary inflammatory index
(DII®) from the University of South Carolina in order
to develop computer and smart phone applications for patient counselling
and dietary intervention in clinical settings. Dr. Nitin Shivappa is an
employee of CHI.